CN Stock MarketDetailed Quotes

688606 Hangzhou Alltest Biotech

Watchlist
  • 66.50
  • -1.42-2.09%
Market Closed Apr 30 15:00 CST
5.27BMarket Cap28.53P/E (TTM)

Hangzhou Alltest Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-15.34%199.92M
-77.73%754.7M
-81.40%559.94M
-85.76%387.85M
-88.75%236.14M
80.88%3.39B
201.96%3.01B
328.52%2.72B
628.17%2.1B
64.98%1.87B
Operating revenue
-15.34%199.92M
-77.73%754.7M
-81.40%559.94M
-85.76%387.85M
-88.75%236.14M
80.88%3.39B
201.96%3.01B
328.52%2.72B
628.17%2.1B
64.98%1.87B
Total operating cost
-19.44%144.14M
-66.17%592.08M
-68.81%437.85M
-73.52%305.91M
-77.30%178.93M
73.28%1.75B
213.10%1.4B
347.60%1.16B
592.03%788.2M
193.69%1.01B
Operating cost
-10.73%99.7M
-71.53%386.54M
-73.04%291.66M
-77.73%207.1M
-83.44%111.69M
61.64%1.36B
232.59%1.08B
411.45%929.81M
714.02%674.49M
316.72%839.93M
Operating tax surcharges
28.80%2.05M
-74.71%7.04M
-81.79%3.7M
-81.94%2.6M
-4.97%1.59M
180.28%27.82M
66.65%20.33M
140.14%14.37M
-26.30%1.67M
-6.24%9.93M
Operating expense
-35.15%10.81M
-53.91%69.29M
-64.18%47.45M
-68.30%32.64M
-60.92%16.67M
202.12%150.34M
338.21%132.46M
465.45%102.98M
598.56%42.67M
50.53%49.76M
Administration expense
-25.74%13.49M
-14.70%66.59M
-25.79%48.45M
-11.59%34.46M
-10.72%18.17M
138.61%78.06M
154.18%65.29M
102.79%38.98M
203.58%20.35M
30.76%32.72M
Financial expense
4.59%-5.08M
17.47%-58.54M
22.50%-43.11M
-19.01%-36.77M
-344.00%-5.32M
-300.76%-70.93M
-393.75%-55.62M
-496.50%-30.9M
217.24%2.18M
-195.13%-17.7M
-Interest expense (Financial expense)
-70.04%132.56K
-33.28%1.45M
-35.03%1.17M
-32.15%833.66K
-41.46%442.38K
224.69%2.17M
--1.8M
--1.23M
--755.67K
--668.76K
-Interest Income (Financial expense)
36.50%-5.37M
16.95%-35.62M
9.24%-29.49M
-37.90%-21.8M
-104.40%-8.45M
-13.14%-42.89M
-75.79%-32.49M
-11.59%-15.81M
-840.22%-4.13M
-3,919.66%-37.9M
Research and development
-35.89%23.16M
-41.55%121.17M
-43.72%89.69M
-34.08%65.88M
-22.89%36.12M
117.16%207.3M
140.80%159.38M
162.69%99.94M
162.93%46.84M
73.22%95.46M
Credit Impairment Loss
-45.58%-11.37M
-102.06%-11.23M
-103.75%-14.11M
-72.34%-10.77M
-85.30%-7.81M
17.91%-5.56M
-281.11%-6.93M
-110.04%-6.25M
-48.54%-4.21M
-48.39%-6.77M
Asset Impairment Loss
68.09%-5.44M
102.00%5.6M
101.48%1.05M
106.72%4.78M
76.00%-17.06M
-7,016.09%-280.06M
-4,577.25%-71.08M
-1,870.70%-71.08M
-5,762.74%-71.08M
-50.22%-3.94M
Other net revenue
Fair value change income
-64.70%3.36M
314.66%32.67M
-83.25%4.96M
-90.61%1.41M
--9.53M
-171.36%-15.22M
--29.63M
--15.01M
----
--21.33M
Invest income
-9.77%4.2M
-64.20%8.63M
-56.10%6.34M
-49.29%6.26M
61.98%4.66M
246.83%24.12M
114.33%14.45M
130.20%12.35M
-23.56%2.88M
34.00%6.95M
Asset deal income
99.28%-6.08K
-178.63%-419.22K
-3,438.20%-535.17K
-489,844.80%-535.17K
-774,917.52%-846.55K
1,004.34%533.17K
-44.92%16.03K
-100.38%-109.23
-100.38%-109.23
---58.96K
Other revenue
38.25%796.95K
-56.82%13.71M
-64.22%9.3M
-56.58%7.99M
-85.47%576.47K
99.67%31.75M
372.85%26M
371.73%18.4M
1,484.45%3.97M
412.10%15.9M
Operating profit
2.32%47.33M
-84.82%211.58M
-91.92%129.1M
-94.07%91.08M
-96.28%46.25M
55.43%1.39B
185.14%1.6B
304.20%1.54B
612.55%1.24B
13.12%896.75M
Add:Non operating Income
11,774.39%100K
-80.76%24.08K
-98.54%13.97K
-95.06%13.97K
-99.47%842.15
114.87%125.17K
2,573.07%957.06K
314,461,866.67%283.02K
263,909,500.00%158.35K
388.02%58.26K
Less:Non operating expense
35.77%271.7K
13.29%14.17M
45.09%14.15M
48.33%13.83M
-96.34%200.11K
879.44%12.51M
688.68%9.75M
817.50%9.32M
547,267,166.00%5.47M
18.98%1.28M
Total profit
2.39%47.16M
-85.71%197.44M
-92.77%114.96M
-94.94%77.26M
-96.28%46.06M
54.26%1.38B
184.18%1.59B
302.90%1.53B
609.50%1.24B
13.12%895.53M
Less:Income tax cost
-56.06%2.51M
-91.25%17.16M
-94.01%13.72M
-97.14%6.44M
-96.95%5.72M
50.94%195.99M
197.07%228.93M
323.76%224.93M
680.56%187.83M
15.48%129.84M
Net profit
10.68%44.64M
-84.79%180.28M
-92.56%101.25M
-94.56%70.83M
-96.16%40.34M
54.82%1.19B
182.12%1.36B
299.51%1.3B
598.12%1.05B
12.73%765.69M
Net profit from continuing operation
10.68%44.64M
-84.79%180.28M
-92.56%101.25M
-94.56%70.83M
-96.16%40.34M
54.82%1.19B
182.12%1.36B
299.51%1.3B
598.12%1.05B
12.73%765.69M
Less:Minority Profit
26.37%-144.58K
-154.94%-295.58K
-283.53%-319.37K
-506.30%-355K
-120.88%-196.37K
--538.05K
--174.02K
--87.37K
---88.9K
----
Net profit of parent company owners
10.50%44.79M
-84.76%180.58M
-92.53%101.57M
-94.54%71.18M
-96.14%40.53M
54.75%1.18B
182.09%1.36B
299.48%1.3B
598.18%1.05B
12.73%765.69M
Earning per share
Basic earning per share
9.80%0.56
-84.75%2.28
-92.54%1.28
-94.52%0.9
-97.38%0.51
-1.32%14.95
79.31%17.16
137.43%16.43
423.12%19.46
-9.93%15.15
Diluted earning per share
9.80%0.56
-84.75%2.28
--1.28
--0.9
--0.51
--14.95
----
----
----
----
Other composite income
153.93%151.35K
-91.58%2.37M
-86.50%3.88M
-66.90%4.76M
-410.05%-280.66K
21,705.78%28.12M
16,975.15%28.78M
24,772.44%14.38M
3,247.81%90.52K
-44.21%128.98K
Other composite income of parent company owners
142.57%144.61K
-91.60%2.36M
-86.52%3.88M
-66.93%4.75M
-464.00%-339.7K
21,710.09%28.13M
16,983.33%28.79M
24,772.44%14.38M
3,345.32%93.32K
-44.21%128.98K
Other composite income of minority owners
-88.58%6.74K
180.83%4.5K
119.25%2.65K
--4.23K
2,205.68%59.05K
---5.56K
---13.79K
----
---2.8K
----
Total composite income
11.83%44.8M
-84.95%182.65M
-92.43%105.13M
-94.26%75.59M
-96.18%40.06M
58.47%1.21B
187.99%1.39B
303.85%1.32B
598.20%1.05B
12.71%765.82M
Total composite income of parent company owners
11.79%44.93M
-84.92%182.94M
-92.41%105.45M
-94.23%75.94M
-96.17%40.19M
58.40%1.21B
187.96%1.39B
303.82%1.32B
598.26%1.05B
12.71%765.82M
Total composite income of minority owners
-0.37%-137.84K
-154.67%-291.09K
-297.67%-316.72K
-501.46%-350.77K
-49.74%-137.33K
--532.49K
--160.23K
--87.37K
---91.71K
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
--
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -15.34%199.92M-77.73%754.7M-81.40%559.94M-85.76%387.85M-88.75%236.14M80.88%3.39B201.96%3.01B328.52%2.72B628.17%2.1B64.98%1.87B
Operating revenue -15.34%199.92M-77.73%754.7M-81.40%559.94M-85.76%387.85M-88.75%236.14M80.88%3.39B201.96%3.01B328.52%2.72B628.17%2.1B64.98%1.87B
Total operating cost -19.44%144.14M-66.17%592.08M-68.81%437.85M-73.52%305.91M-77.30%178.93M73.28%1.75B213.10%1.4B347.60%1.16B592.03%788.2M193.69%1.01B
Operating cost -10.73%99.7M-71.53%386.54M-73.04%291.66M-77.73%207.1M-83.44%111.69M61.64%1.36B232.59%1.08B411.45%929.81M714.02%674.49M316.72%839.93M
Operating tax surcharges 28.80%2.05M-74.71%7.04M-81.79%3.7M-81.94%2.6M-4.97%1.59M180.28%27.82M66.65%20.33M140.14%14.37M-26.30%1.67M-6.24%9.93M
Operating expense -35.15%10.81M-53.91%69.29M-64.18%47.45M-68.30%32.64M-60.92%16.67M202.12%150.34M338.21%132.46M465.45%102.98M598.56%42.67M50.53%49.76M
Administration expense -25.74%13.49M-14.70%66.59M-25.79%48.45M-11.59%34.46M-10.72%18.17M138.61%78.06M154.18%65.29M102.79%38.98M203.58%20.35M30.76%32.72M
Financial expense 4.59%-5.08M17.47%-58.54M22.50%-43.11M-19.01%-36.77M-344.00%-5.32M-300.76%-70.93M-393.75%-55.62M-496.50%-30.9M217.24%2.18M-195.13%-17.7M
-Interest expense (Financial expense) -70.04%132.56K-33.28%1.45M-35.03%1.17M-32.15%833.66K-41.46%442.38K224.69%2.17M--1.8M--1.23M--755.67K--668.76K
-Interest Income (Financial expense) 36.50%-5.37M16.95%-35.62M9.24%-29.49M-37.90%-21.8M-104.40%-8.45M-13.14%-42.89M-75.79%-32.49M-11.59%-15.81M-840.22%-4.13M-3,919.66%-37.9M
Research and development -35.89%23.16M-41.55%121.17M-43.72%89.69M-34.08%65.88M-22.89%36.12M117.16%207.3M140.80%159.38M162.69%99.94M162.93%46.84M73.22%95.46M
Credit Impairment Loss -45.58%-11.37M-102.06%-11.23M-103.75%-14.11M-72.34%-10.77M-85.30%-7.81M17.91%-5.56M-281.11%-6.93M-110.04%-6.25M-48.54%-4.21M-48.39%-6.77M
Asset Impairment Loss 68.09%-5.44M102.00%5.6M101.48%1.05M106.72%4.78M76.00%-17.06M-7,016.09%-280.06M-4,577.25%-71.08M-1,870.70%-71.08M-5,762.74%-71.08M-50.22%-3.94M
Other net revenue
Fair value change income -64.70%3.36M314.66%32.67M-83.25%4.96M-90.61%1.41M--9.53M-171.36%-15.22M--29.63M--15.01M------21.33M
Invest income -9.77%4.2M-64.20%8.63M-56.10%6.34M-49.29%6.26M61.98%4.66M246.83%24.12M114.33%14.45M130.20%12.35M-23.56%2.88M34.00%6.95M
Asset deal income 99.28%-6.08K-178.63%-419.22K-3,438.20%-535.17K-489,844.80%-535.17K-774,917.52%-846.55K1,004.34%533.17K-44.92%16.03K-100.38%-109.23-100.38%-109.23---58.96K
Other revenue 38.25%796.95K-56.82%13.71M-64.22%9.3M-56.58%7.99M-85.47%576.47K99.67%31.75M372.85%26M371.73%18.4M1,484.45%3.97M412.10%15.9M
Operating profit 2.32%47.33M-84.82%211.58M-91.92%129.1M-94.07%91.08M-96.28%46.25M55.43%1.39B185.14%1.6B304.20%1.54B612.55%1.24B13.12%896.75M
Add:Non operating Income 11,774.39%100K-80.76%24.08K-98.54%13.97K-95.06%13.97K-99.47%842.15114.87%125.17K2,573.07%957.06K314,461,866.67%283.02K263,909,500.00%158.35K388.02%58.26K
Less:Non operating expense 35.77%271.7K13.29%14.17M45.09%14.15M48.33%13.83M-96.34%200.11K879.44%12.51M688.68%9.75M817.50%9.32M547,267,166.00%5.47M18.98%1.28M
Total profit 2.39%47.16M-85.71%197.44M-92.77%114.96M-94.94%77.26M-96.28%46.06M54.26%1.38B184.18%1.59B302.90%1.53B609.50%1.24B13.12%895.53M
Less:Income tax cost -56.06%2.51M-91.25%17.16M-94.01%13.72M-97.14%6.44M-96.95%5.72M50.94%195.99M197.07%228.93M323.76%224.93M680.56%187.83M15.48%129.84M
Net profit 10.68%44.64M-84.79%180.28M-92.56%101.25M-94.56%70.83M-96.16%40.34M54.82%1.19B182.12%1.36B299.51%1.3B598.12%1.05B12.73%765.69M
Net profit from continuing operation 10.68%44.64M-84.79%180.28M-92.56%101.25M-94.56%70.83M-96.16%40.34M54.82%1.19B182.12%1.36B299.51%1.3B598.12%1.05B12.73%765.69M
Less:Minority Profit 26.37%-144.58K-154.94%-295.58K-283.53%-319.37K-506.30%-355K-120.88%-196.37K--538.05K--174.02K--87.37K---88.9K----
Net profit of parent company owners 10.50%44.79M-84.76%180.58M-92.53%101.57M-94.54%71.18M-96.14%40.53M54.75%1.18B182.09%1.36B299.48%1.3B598.18%1.05B12.73%765.69M
Earning per share
Basic earning per share 9.80%0.56-84.75%2.28-92.54%1.28-94.52%0.9-97.38%0.51-1.32%14.9579.31%17.16137.43%16.43423.12%19.46-9.93%15.15
Diluted earning per share 9.80%0.56-84.75%2.28--1.28--0.9--0.51--14.95----------------
Other composite income 153.93%151.35K-91.58%2.37M-86.50%3.88M-66.90%4.76M-410.05%-280.66K21,705.78%28.12M16,975.15%28.78M24,772.44%14.38M3,247.81%90.52K-44.21%128.98K
Other composite income of parent company owners 142.57%144.61K-91.60%2.36M-86.52%3.88M-66.93%4.75M-464.00%-339.7K21,710.09%28.13M16,983.33%28.79M24,772.44%14.38M3,345.32%93.32K-44.21%128.98K
Other composite income of minority owners -88.58%6.74K180.83%4.5K119.25%2.65K--4.23K2,205.68%59.05K---5.56K---13.79K-------2.8K----
Total composite income 11.83%44.8M-84.95%182.65M-92.43%105.13M-94.26%75.59M-96.18%40.06M58.47%1.21B187.99%1.39B303.85%1.32B598.20%1.05B12.71%765.82M
Total composite income of parent company owners 11.79%44.93M-84.92%182.94M-92.41%105.45M-94.23%75.94M-96.17%40.19M58.40%1.21B187.96%1.39B303.82%1.32B598.26%1.05B12.71%765.82M
Total composite income of minority owners -0.37%-137.84K-154.67%-291.09K-297.67%-316.72K-501.46%-350.77K-49.74%-137.33K--532.49K--160.23K--87.37K---91.71K----
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion--------
Auditor ----------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg